|
|
Article: Bracco Diagnostics and AmeriNet Expand Agreement on Contrast Agents; Bracco Earns Elite Preferred Contract for MRI Agent ProHance.
- Article from:
- Business Wire
- Article date:
- February 12, 2003
CopyrightCOPYRIGHT 2003 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors/Health & Medical Writers
PRINCETON, N.J.--(BUSINESS WIRE)--Feb. 12, 2003
Bracco Diagnostics Inc. and AmeriNet, Inc. today announced an agreement designating Bracco as an Elite Preferred provider of Magnetic Resonance Imaging (MRI) contrast agents for AmeriNet members.
This Elite Preferred (EP) agreement covers Bracco's ProHance(R) (gadoteridol injection), awarding Bracco with purchases from pre-commited AmeriNet members, and dual-source status with all other AmeriNet members.
This contract is in addition to two other AmeriNet agreements with Bracco that include the non-ionic compound Isovue(R) (iopamidol injection). ...